IMPAKT 2013: Gene expression test distinguishes between breast cancer patients at high or low risk of late recurrence
A TEST THAT measures the expression levels of 58 genes in oestrogen receptor-positive breast cancers…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Professor Robin Room’s recommendations to curb Australia’s alcohol consumption
AUSTRALIA should reduce trading hours for clubs and pubs, raise the minimum age for buying…
Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma
A PROSPECTIVE RANDOMISED Trial From the Lymphoma Working Party of the European Group for Blood…
Wide role for new drug targeting skin cancer gene
A DRUG TREATMENT that successfully targets a gene involved in skin cancer has been tested…
Tens of thousands of lives saved in the running battle against cancers
MORE than 61,000 people have been saved from dying of cancer in Australia over the…
Conquer Cancer Foundation Awards $4.45 Million To More Than 50 Leading Investigators To Support Promising Oncology Research Careers
TODAY the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) announces the…
Cancer firm AVO buys Large Hadron Collider spin-off
A BRITISH CANCER treatment company is buying a business spun off from technology developed from…
Researchers look to emus for the good oil
EMU oil has been found to help treat a variety of common bowel diseases as…
Surviving prostate cancer: a prostate surgeon’s story
PROFESSOR Roger Kirby is one of the world’s leading prostate surgeons. So when he developed…
ESMO Debate: Should Neoadjuvant Data Be Used To Speed Drug Approval?
VIENNA—Can neoadjuvant breast cancer data be used to accelerate drug development? At the recent annual…